The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer
Clinical trial NCT04212598 · COMPLETED
Trial details
- NCT number
- NCT04212598
- Sponsor
- Wuhan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2024-11-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.